They concluded that the greater risk of BRAF-mutated PTCs among those with high BMI suggests that the association may not merely reflect greater health care service use and indicates an independent relationship between obesity and clinically relevant TC [17]. The gene discussed is BRAF; the disease is obesity disorder.